4//SEC Filing
Garratt Michael A 4
Accession 0001127602-22-005061
CIK 0001122976other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:16 PM ET
Size
13.8 KB
Accession
0001127602-22-005061
Insider Transaction Report
Form 4
AVIENT CORPAVNT
Garratt Michael A
SVP, President of PP&S
Transactions
- Award
Restricted Stock Units
2022-02-14+4,550→ 4,550 totalFrom: 2025-02-14Exp: 2025-02-14→ Common Stock (4,550 underlying) - Award
Stock Appreciation Rights
2022-02-14+16,000→ 16,000 totalExercise: $52.64Exp: 2032-02-14→ Common Stock (16,000 underlying) - Exercise/Conversion
Common Stock
2022-02-11+5,800→ 24,610 total - Tax Payment
Common Stock
2022-02-11$52.64/sh−2,646$139,285→ 21,964 total - Exercise/Conversion
Restricted Stock Units
2022-02-11−5,800→ 0 totalFrom: 2022-02-11Exp: 2022-02-11→ Common Stock (5,800 underlying)
Holdings
- 14,290.129(indirect: Supplemental Plan)
Common Stock
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
- [F2]Includes dividend equivalents earned with respect to the vested restricted stock units.
- [F3]Represents shares of Avient common stock that were withheld solely to satisfy the tax withholding obligation applicable to the vesting of restricted stock units on February 11, 2022.
- [F4]The information in this report is based on a plan statement as of February 11, 2022.
- [F5]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.
Documents
Issuer
AVIENT CORP
CIK 0001122976
Entity typeother
Related Parties
1- filerCIK 0001582428
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 5:16 PM ET
- Size
- 13.8 KB